Retail sales in the U.S. fell by more than anticipated in the month of September, according to a report released by the Commerce Department on Wednesday, with the decrease partly reflecting the recent drop in gas prices.
The report said retail sales dropped by 0.3 percent in September after climbing by 0.6 percent in August. Economists had been expecting sales to edge down by just 0.1 percent.
Excluding a pullback in auto sales, retail sales dipped by 0.2 percent in September compared to a 0.3 percent increase in the previous month. Ex-auto sales had been expected to rise by another 0.3 percent.
For comments and feedback contact: editorial@rttnews.com
Economic News
What parts of the world are seeing the best (and worst) economic performances lately? Click here to check out our Econ Scorecard and find out! See up-to-the-moment rankings for the best and worst performers in GDP, unemployment rate, inflation and much more.
November 03, 2026 10:34 ET A key date in rare disease research. BridgeBio Pharma’s BBP-418 is under FDA Priority Review for limb-girdle muscular dystrophy type 2I/R9, a rare genetic disease with no approved treatment. The FDA decision is targeted for November 27. If approved, BBP-418 could become the first approved therapy for any form of limb-girdle muscular dystrophy.